39 However, cancer cells frequently upregulate cyclin-dependent kinases (CDKs), which counteract the effects of these cell cycle inhibitors.40 In advanced-stage disease, TGF-β thus acts as a pro-oncogenic factor that promotes tumour invasion, angiogenesis and immune tolerance.41 This evidence concerns the gene TGFB1 and cancer.